The LDOC1L Polyclonal Antibody (PACO01020) is an essential tool for researchers studying LDOC1L, a key player in the regulation of cell growth and differentiation. This antibody, developed using rabbits, displays high reactivity with human samples and is validated for use in various applications including Western blotting.LDOC1L, also known as Leucine zipper down-regulated in cancer 1-like protein, is involved in cellular processes that control cell proliferation and differentiation. Its role in cancer development and progression makes it a promising target for studies in cancer biology and therapeutic development.
By specifically binding to LDOC1L protein, this antibody enables accurate detection and analysis of this molecule in various cell types, making it ideal for investigating its function in different cellular contexts. Researchers in the fields of oncology and cell biology will benefit greatly from the use of this antibody in their study of LDOC1L and its potential implications in cancer research and therapy development.
Antibody Name:
LDOC1L Antibody
Antibody SKU:
PACO01020
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, WB, IHC
Recommended Dilutions:
WB:1:500-1:2000, IHC:1:100-1:300
Species Reactivity:
Human, Mouse
Immunogen:
synthesized peptide derived from the Internal region of human LDOC1L.
Form:
Liquid
Storage Buffer:
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Clonality:
Polyclonal
Isotype:
IgG
Conjugate:
Non-conjugated
Synonyms:
LDOC1L; MAR6; MART6; Protein LDOC1L; Leucine zipper protein down-regulated in cancer cells-like; Mammalian retrotransposon-derived protein 6
